Emeno Biotech
Latest round
- Angel
Last raised
- Jun 2025
Total raised
- Undisclosed
Investors
- 1
About Emeno Biotech
Founded in 2025 and based in Changzhou, China, Emeno Biotech is a high-tech enterprise focusing on the research, development, production and sales of medical devices. The company is committed to providing medical device solutions for medical institutions and patients. Its products cover diagnostic equipment, therapeutic equipment and other fields. It generates revenue from providing its products diagnostic equipment, therapeutic equipment to medical institutions and patients.
Who invested in Emeno Biotech
1 investor across 1 round
See all investors in Emeno Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jun 17, 2025
Amount
Undisclosed
Investors
Questions about Emeno Biotech
Who invested in Emeno Biotech?
Emeno Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emeno Biotech raised?
Emeno Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Emeno Biotech last raise money?
Emeno Biotech's most recent round on record is a Angel, in Jun 2025.
What does Emeno Biotech do?
Founded in 2025 and based in Changzhou, China, Emeno Biotech is a high-tech enterprise focusing on the research, development, production and sales of medical devices.
Where is Emeno Biotech headquartered?
Emeno Biotech is headquartered in Changzhou, China.
Which VCs invest in companies like Emeno Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Emeno Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Angel
Raising like Emeno Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.